ReviewFrontiers in global women's health2026
Substance use patterns among sexual minority women: a mini review.
Review in Frontiers in global women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Sexual minority women (SMW), including lesbian, bisexual, and other non-heterosexual women, experience higher rates of substance use (SU) and substance use disorders (SUDs) than heterosexual women, yet remain relatively underrepresented in the literature. Objectives: This structured mini-review aimed to synthesize evidence on prevalence patterns, determinants, intersectional influences, treatment barriers, and intervention approaches related to substance use among SMW. Methods: A structured narrative review of epidemiological studies, reviews, and meta-analyses was undertaken using predefined thematic domains: epidemiology, determinants/pathways, intersectionality, and treatment-related issues. Evidence was synthesized narratively because of heterogeneity in populations, outcome measures, and study designs. Results: Across much of the available literature, SMW show elevated prevalence of alcohol, tobacco, cannabis, and polysubstance use compared with heterosexual women, with bisexual women frequently identified as the highest-risk subgroup. Reported determinants include minority stress-related processes, internalized stigma, discrimination, victimization, and adverse childhood experiences. Intersectional disadvantage, including racial/ethnic minority status and socioeconomic marginalization, may further amplify vulnerability. Treatment access is hindered by stigma, limited LGBTQ+-affirming services, and gaps in provider cultural competence. Evidence for SMW-specific interventions remains limited. Conclusions: Available evidence suggests that substance use disparities among SMW are shaped by minority stress, intersecting social disadvantage, and barriers to inclusive care. More methodologically rigorous, intersectionally informed, and geographically diverse research is needed, alongside development of identity-affirming and trauma-informed interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.